Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 4 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Steroid in the Treatment of Outpatient COVID-19: A Multicenter Randomized Controlled Trial.
Adv Biomed Res. 2023 May 15;12:122. doi: 10.4103/abr.abr_72_22. eCollection 2023.
Adv Biomed Res. 2023.
PMID: 37434926
Free PMC article.
Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.
Vaezi A, Salmasi M, Soltaninejad F, Salahi M, Javanmard SH, Amra B.
Vaezi A, et al. Among authors: salahi m.
Adv Respir Med. 2023 Jan 28;91(1):18-25. doi: 10.3390/arm91010004.
Adv Respir Med. 2023.
PMID: 36825938
Free PMC article.
Clinical Trial.
Item in Clipboard
Is Chronic Kidney Disease, a Predictor of In-Hospital Mortality in Coronavirus Disease 2019 (COVID-19) Patients?
Moeinzadeh F, Raeisi V, Babahajiani M, Mortazavi M, Pourajam S, Seirafian S, Shirzadi M, Taheri S, Salahi M, Mansourian M, Toghyani A, Zamani Z.
Moeinzadeh F, et al. Among authors: salahi m.
Adv Biomed Res. 2023 Feb 25;12:39. doi: 10.4103/abr.abr_352_21. eCollection 2023.
Adv Biomed Res. 2023.
PMID: 37057234
Free PMC article.
Item in Clipboard
Efficacy of Hydroxychloroquine in Pre-exposure Severe Acute Respiratory Syndrome Coronavirus 2 Prophylaxis among High-Risk HealthCare Workers: A Multicenter Study.
Nasri E, Fakhim H, Salahi M, Ghafel S, Pourajam S, Darakhshandeh A, Kassaian N, Sadeghi S, Ataei B, Javanmard SH, Vaezi A.
Nasri E, et al. Among authors: salahi m.
Adv Biomed Res. 2023 Jan 27;12:3. doi: 10.4103/abr.abr_104_21. eCollection 2023.
Adv Biomed Res. 2023.
PMID: 36926426
Free PMC article.
Item in Clipboard
Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial.
Karimi M, Zarei A, Soleymani S, Jamalimoghadamsiahkali S, Asadi A, Shati M, Jafari M, Rezadoost H, Kordafshar G, Naghizadeh A, Mardi R, Namiranian P, Khamechi SP, Ansari N, Adel Mehraban MS, Aliakbarzadeh H, Khanavi M, Esmaealzadeh N, Moravveji A, Salahi M, Khoi M, Razzaghi R, Banafshe HR, Alizadeh M, Akhbari M, Atharizadeh M, Izadikhah A, Elsagh M, Hossein Zade Ghahnavieh M, Eghbalian F, Vanai A, Izadi H, Moravej SAA, Jazayeri SF, Bayat H, Emadi Koochak H, Zargaran A.
Karimi M, et al. Among authors: salahi m.
Phytother Res. 2021 Nov;35(11):6295-6309. doi: 10.1002/ptr.7277. Epub 2021 Oct 4.
Phytother Res. 2021.
PMID: 34606123
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite